Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Raye Z. Litten, Bonnie B. Wilford, Daniel E. Falk, Megan L. Ryan & Joanne B. Fertig. (2016) Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety. Substance Abuse 37:2, pages 286-298.
Read now
Read now
Yoshikazu Uto. (2015) 1,2-Benzisoxazole compounds: a patent review (2009 – 2014). Expert Opinion on Therapeutic Patents 25:6, pages 643-662.
Read now
Read now
Marco Mula. (2013) Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults. Drug Design, Development and Therapy 7, pages 397-402.
Read now
Read now
Gaetano Zaccara, Luciana Tramacere & Massimo Cincotta. (2011) Drug safety evaluation of zonisamide for the treatment of epilepsy. Expert Opinion on Drug Safety 10:4, pages 623-631.
Read now
Read now
Benjamin Cretin & Edouard Hirsch. (2010) Adjunctive antiepileptic drugs in adult epilepsy: how the first add-on could be the last. Expert Opinion on Pharmacotherapy 11:7, pages 1053-1067.
Read now
Read now
Gaetano Zaccara & Luigi M Specchio. (2009) Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature. Neuropsychiatric Disease and Treatment 5, pages 249-259.
Read now
Read now
Articles from other publishers (37)
Xin-Yi Chen, Cui Liu, Yan Xue & Lei Chen. (2023) Changed firing activity of nigra dopaminergic neurons in Parkinson's disease. Neurochemistry International 162, pages 105465.
Crossref
Crossref
András H. Lékó, Mehdi Farokhnia & Lorenzo Leggio. 2023. Alcohol and Alcohol-related Diseases. Alcohol and Alcohol-related Diseases
261
288
.
Neha Hanna Daniel, Ananya Aravind & Poonam Thakur. (2021) Are ion channels potential therapeutic targets for Parkinson’s disease?. NeuroToxicology 87, pages 243-257.
Crossref
Crossref
Rohit Pal, Karanvir Singh, Shah Alam Khan, Pooja Chawla, Bhupinder Kumar & Md Jawaid Akhtar. (2021) Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction. European Journal of Medicinal Chemistry 226, pages 113890.
Crossref
Crossref
Rohit Pal, Bhupinder Kumar, Md. Jawaid Akhtar & Pooja A. Chawla. (2021) Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies. Bioorganic Chemistry 115, pages 105230.
Crossref
Crossref
Ricardo Matos, Brendan P. Noonan, Deanna M.W. Schaefer, James Morrisey, Curtis Dewey, Elizabeth L. Buckles & Dawn Boothe. (2021)
Pharmacokinetics of zonisamide after oral single dosing and multiple‐dose escalation administration in domestic chickens (
Gallus gallus
)
. Veterinary Medicine and Science 7:5, pages 1928-1937.
Crossref
Crossref
Joana Smirnovienė, Alexey Smirnov, Audrius Zakšauskas, Asta Zubrienė, Vytautas Petrauskas, Aurelija Mickevičiūtė, Vilma Michailovienė, Edita Čapkauskaitė, Elena Manakova, Saulius Gražulis, Lina Baranauskienė, Wen‐Yih Chen, John E. Ladbury & Daumantas Matulis. (2021) Switching the Inhibitor‐Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII. ChemistryOpen 10:5, pages 567-580.
Crossref
Crossref
Junna He, Xiangjian Zhang, Weiliang He, Yanzhao Xie, Yanxia Chen, Yang Yang & Rong Chen. (2021) Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis. Brazilian Journal of Medical and Biological Research 54:4.
Crossref
Crossref
Krista A. Keller, David Sanchez-Migallon Guzman, Dawn M. Boothe, Marike Visser, Ricardo E. de Matos, Olivia A. Petritz, Philip H. Kass & Joanne R. Paul-Murphy. (2019) Pharmacokinetics and safety of zonisamide after oral administration of single and multiple doses to Hispaniolan Amazon parrots (Amazona ventralis). American Journal of Veterinary Research 80:2, pages 195-200.
Crossref
Crossref
Lorenzo Leggio, Daniel E. Falk, Megan L. Ryan, Joanne Fertig & Raye Z. Litten. 2020. Substance Use Disorders. Substance Use Disorders
443
462
.
Richard Kast. (2018) Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment. Medical Sciences 6:4, pages 84.
Crossref
Crossref
Rani A. Sarkis, Johny Nicolas & Jong Woo Lee. (2017) Tolerability of lacosamide or zonisamide in elderly patients with seizures. Seizure 49, pages 1-4.
Crossref
Crossref
Jack Chen. (2017) Zonisamide for the Management of Essential Tremor: An Illustrative Case Report on Long-Term Effectiveness. Journal of Contemporary Pharmacy Practice 64:1, pages 11-14.
Crossref
Crossref
Raye Z. Litten, Daniel E. Falk, Megan L. Ryan, Joanne Fertig & Lorenzo Leggio. 2018. The Neuropharmacology of Alcohol. The Neuropharmacology of Alcohol
579
613
.
Feixiong Cheng, Junfei Zhao, Michaela Fooksa & Zhongming Zhao. (2016) A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes. Journal of the American Medical Informatics Association 23:4, pages 681-691.
Crossref
Crossref
Júlia Miro, Sònia Jaraba, Roser Juvany, Milagrosa Santurino, Sara Cobo & Mercè Falip. (2016) Could Adult European Pharmacoresistant Epilepsy Patients Be Treated With Higher Doses of Zonisamide?. Clinical Neuropharmacology 39:3, pages 121-124.
Crossref
Crossref
Michael Shapiro, Adam Reid, Brian Olsen, Michael Taasan, Joseph McNamara & Mathew Nguyen. (2015) Topiramate, zonisamide and weight loss in children and adolescents prescribed psychiatric medications. The International Journal of Psychiatry in Medicine 51:1, pages 56-68.
Crossref
Crossref
Shang‐Yeong Kwan, Yao‐Chung Chuang, Chin‐Wei Huang, Ta‐Cheng Chen, Shuo‐Bin Jou & Amitabh Dash. (2015) Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy. CNS Neuroscience & Therapeutics 21:9, pages 683-691.
Crossref
Crossref
J. Helen Cross, Stéphane Auvin, Anna Patten & Luigi Giorgi. (2014) Safety and tolerability of zonisamide in paediatric patients with epilepsy. European Journal of Paediatric Neurology 18:6, pages 747-758.
Crossref
Crossref
Yasemin Topçu, Erhan Bayram, Seda Özbal, Uluç Yiş, Kazım Tuğyan, Pakize Karaoğlu, Abdullah Kumral, Osman Yılmaz & Semra Hız Kurul. (2014) Zonisamide attenuates hyperoxia-induced apoptosis in the developing rat brain. Neurological Sciences 35:11, pages 1769-1775.
Crossref
Crossref
Mathew L. Nguyen, Mustafa H. Pirzada & Michael A. Shapiro. (2013) Zonisamide for Weight Loss in Adolescents. The Journal of Pediatric Pharmacology and Therapeutics 18:4, pages 311-314.
Crossref
Crossref
Salvatore Condello, Monica Currò, Nadia Ferlazzo, Gregorio Costa, Giuseppa Visalli, Daniela Caccamo, Laura Rosa Pisani, Cinzia Costa, Paolo Calabresi, Riccardo Ientile & Francesco Pisani. (2013) Protective Effects of Zonisamide Against Rotenone-Induced Neurotoxicity. Neurochemical Research 38:12, pages 2631-2639.
Crossref
Crossref
Lucy Chen & Jianren Mao. (2013) Update on Neuropathic Pain Treatment: Ion Channel Blockers and Gabapentinoids. Current Pain and Headache Reports 17:9.
Crossref
Crossref
Kamal M. Matar. (2013) Impact of Pregnancy on Zonisamide Pharmacokinetics in Rabbits. BioMed Research International 2013, pages 1-5.
Crossref
Crossref
Susan L. McElroy, Erin Winstanley, Nicole Mori, Brian Martens, Jessica McCoy, Dianna Moeller, Anna I. Guerdjikova & Paul E. Keck. (2012) A Randomized, Placebo-Controlled Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain. Journal of Clinical Psychopharmacology 32:2, pages 165-172.
Crossref
Crossref
Yusuke Iwata, Sachiko Irie, Hiroyuki Uchida, Takefumi Suzuki, Koichiro Watanabe, Satoru Iwashita & Masaru Mimura. (2012) Effects of zonisamide on tardive dyskinesia: A preliminary open-label trial. Journal of the Neurological Sciences 315:1-2, pages 137-140.
Crossref
Crossref
Glenn T. Clark & Antonia. Teruel. 2012. Orofacial Pain. Orofacial Pain
95
114
.
R. ShahienK. Beiruti. (2012) Preventive Agents for Migraine: Focus on the Antiepileptic Drugs. Journal of Central Nervous System Disease 4, pages JCNSD.S9049.
Crossref
Crossref
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
461
479
.
JaeHyoung Lim, Young-Hoon Ko, Sook-Haeng Joe, Changsu Han, Moon-Soo Lee & Jaewon Yang. (2011) Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:8, pages 1918-1921.
Crossref
Crossref
So-Hee Eun, Heung Dong Kim, Baik-Lin Eun, In Kyu Lee, Hee Jung Chung, Joon Sik Kim, Hoon-Chul Kang, Young-Mock Lee, Eun Sook Suh, Dong Wook Kim, Soyong Eom, Joon Soo Lee & Han Ku Moon. (2011) Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. Seizure 20:7, pages 558-563.
Crossref
Crossref
Jacqueline A. French & Deana M. Gazzola. (2011) New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?. Therapeutic Advances in Drug Safety 2:4, pages 141-158.
Crossref
Crossref
Malte SCHWARTZ, Karen R. MUÑANA & Natasha J. OLBY. (2011) Possible Drug-Induced Hepatopathy in a Dog Receiving Zonisamide Monotherapy for Treatment of Cryptogenic Epilepsy. Journal of Veterinary Medical Science 73:11, pages 1505-1508.
Crossref
Crossref
Gabriel Rubio, Francisco López-Muñoz, Francisco Ferre, Isabel Martínez-Gras, Guillermo Ponce, José M. Pascual, Miguel A. Jiménez-Arriero & Cecilio Alamo. (2010) Effects of Zonisamide in the Treatment of Alcohol Dependence. Clinical Neuropharmacology 33:5, pages 250-253.
Crossref
Crossref
Thomas W. Rösler, Oscar Arias-Carrión & Günter U. Höglinger. (2010) Zonisamide: Aspects in neuroprotection. Experimental Neurology 224:2, pages 336-339.
Crossref
Crossref
D. Kurzwelly, U. Herrlinger & M. Simon. 2010. Low-Grade Gliomas. Low-Grade Gliomas
81
111
.
Michael R. Clark. (2009) Psychiatric issues in chronic pain. Current Psychiatry Reports 11:3, pages 243-250.
Crossref
Crossref